Journal: Current drug metabolism

Article Title: E-MHK-0103 (Mineraxinª): A Novel Nutraceutical with Biological Properties in Menopausal Conditions.

PMID/MRN: 27756198

Publication Date: 2016-Oct-14

Abstract:

Menopause is a natural event in women«s lives leading to the cessation of menstruation and the reproductive function due to loss of the ovarian follicular function. Menopause-derived estrogen deprivation and related endocrine factors are linked to some symptoms of middle-aged women, such as hot flashes, aches, joint pain, stiffness, depressed mood, bone degeneration, nutritional dysfunction, or difficulty to maintain body mass. Clinical approaches to these problems often involve hormone replacement therapy (HRT) and other modalities of therapeutic intervention. However, recent evidence shows that medium- to long-term HRT may bring about negative consequences for women«s health according to the risk-benefit balance. These concerns and the well-known side effects associated with other pharmacological alternatives have led physicians and patients to pursue new strategies to alleviate their symptoms. As a physiological state, the first recommended option in the management of menopausal symptoms is a natural and healthy therapy, alone or in combination with pharmacotherapy in severe cases. Among other natural alternatives, E-MHK-0103, a nutraceutical lipoprotein extracted from Atlantic Mytilus galloprovincialis, was found to have beneficial properties on the hot flashes, mood swings, joint pain and bone stability associated with its glucosamine-related anti-inflammatory effect and its high content of vitamins, minerals, iron and other substances, such as selenium and vitamin E. A significant increase in serum growth hormone, mediated by the hepatic secretion of insulin growth factor-1, and a slight decrease in bone alkaline phosphatase, calcium and ?-crosslaps concentrations contribute to its beneficial impact on bone turnover. E-MHK-0103 also showed a powerful antioxidant effect and an increase in iron stores of particular importance in women with low basal ferritin levels.